Volume 30, Number 6—June 2024
Synopsis
Severe Human Parainfluenza Virus Community- and Healthcare-Acquired Pneumonia in Adults at Tertiary Hospital, Seoul, South Korea, 2010–2019
Joung Ha Park1, Sang-Bum Hong1, Jin Won Huh, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Heungsup Sung, Kyung Hyun Do, Sung-Han Kim, Sang-Oh Lee, Yang Soo Kim, Chae-Man Lim, Younsuck Koh, and Sang-Ho Choi
Table 4
Univariate and multivariate analyses of risk factors for severe human parainfluenza virus community- and healthcare-acquired pneumonia in adults at a tertiary hospital in Seoul, South Korea, 2010–2019*
| Variable | Univariate analysis |
Multivariate analysis |
|||
|---|---|---|---|---|---|
| Unadjusted odds ratio (95% CI) | p value | Adjusted odds ratio (95% CI) | p value | ||
| Hospital-acquired HPIV | 3.38 (1.67–6.84) | 0.001 | 2.21 (1.00–4.86) | 0.049 | |
| SOFA score | 1.29 (1.16–1.43) | <0.001 | 1.29 (1.15–1.44) | <0.001 | |
| Hematologic malignancy | 3.46 (1.63–7.33) | 0.001 | 1.35 (0.53–3.40) | 0.53 | |
| Fungal co-infection | 4.38 (1.20–15.99) | 0.03 | 4.64 (1.05–20.63) | 0.04 | |
*Analyses of risk factors associated with 90-day mortality rates for patients with severe HPIV pneumonia. HPIV, human parainfluenza virus; SOFA, sequential organ failure assessment.
1These authors contributed equally to this article.
Page created: April 19, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.